Skip Navigation LinksHome > November 2013 - Volume 113 - Issue 11 > Olmesartan Linked to Spruelike Enteropathy
AJN, American Journal of Nursing:
doi: 10.1097/01.NAJ.0000437107.76232.c4
Drug Watch

Olmesartan Linked to Spruelike Enteropathy

Aschenbrenner, Diane S. MS, RN

Collapse Box

Abstract

* There appears to be a relationship between the antihypertensive drug olmesartan medoxomil and spruelike enteropathy. This condition develops after long-term use of the drug, usually two years or more after the start of therapy.

* Patients who develop diarrhea and weight loss but don't have celiac sprue should be taken off olmesartan.

© 2013 Lippincott Williams & Wilkins. All rights reserved.

Login